Autologous Blood Transfusion

Subscribe to Selected New Research on Autologous Blood Transfusion

514 relevant articles (22 outcomes, 47 trials/studies) found for this Therapy

Description: Reinfusion of blood or blood products derived from the patient's own circulation. (Dorland, 27th ed)

Also Known As:

Blood Transfusion, Autologous; Autologous Blood Transfusions; Blood Transfusions, Autologous; Transfusion, Autologous Blood; Transfusions, Autologous Blood; Autotransfusions; Autotransfusion

Relationship Network

Therapy Context: Research Results

Therapeutics: 5195

Biological Therapy: 773

Blood Transfusion: 8375

Autologous Blood Transfusion: 514

Experts

1.	Selo-Ojeme, D O: 3 articles (02/2007 - 09/2001)
2.	Mitsui, Takashi: 2 articles (04/2007 - 01/2006)
3.	Nakamura, Hiromi: 2 articles (04/2007 - 01/2006)
4.	Takeda, Akihiro: 2 articles (04/2007 - 01/2006)
5.	Yamada, Takashi: 2 articles (03/2005 - 04/2003)
6.	Mori, Hiroshi: 2 articles (03/2005 - 04/2003)
7.	Taniguchi, H: 2 articles (09/2001 - 05/2001)
8.	Koh, T: 2 articles (09/2001 - 05/2001)
9.	Mugitani, T: 2 articles (09/2001 - 05/2001)
10.	Kitagawa, K: 2 articles (09/2001 - 05/2001)

Related Diseases

1.	Hemorrhage 05/01/2004 - "BACKGROUND: The aim of this study was to ascertain whether cell salvage and autotransfusion after first time elective coronary artery bypass grafting is associated with a significant reduction in the use of homologous blood, a clinically significant derangement of postoperative clotting profiles, or an increased risk of postoperative bleeding" 11/01/1986 - "Bleeding, aspiration, and autotransfusion of approximately 3 estimated blood volumes produced small changes in hematologic and coagulation studies" 06/01/2008 - "Uncontrolled hemorrhage is associated with more complex surgery requiring longer bypass times and more autotransfusion." 10/01/2004 - "The mean operation time is 5 hours and 56 minutes, and the mean volume of intraoperative bleeding amounted to 1,417 ml. Autologous blood transfusion was prepared for all 3 patients and transfused them during the operation" 11/01/2003 - "Allogenic or autologous blood transfusion was not necessary, nor was any bleeding noticed post-operatively" Get all the results and reference details, order at left...
2.	Wounds and Injuries (Trauma) 05/01/1996 - "The use of autotransfusion may be beneficial in pediatric trauma victims." 06/01/1977 - "Preliminary usage in thirty trauma patients who underwent autotransfusion of 60 units of blood indicated the device was simple to utilize, efficacious, inexpensive, cost-effective, and safe." 08/01/1994 - "Given the lower success rates for nonoperative observation in grade III splenic trauma, we believe laparoscopic evaluation of splenic injury may offer an improved assessment over computed tomography (CT) scanning by localizing and quantitating the source of blood loss while at the same time enabling the surgeon to perform laparoscopically assisted blood salvage, autotransfusion, and laparoscopic repair" 08/01/1995 - "One hundred forty-four patients who underwent primary total knee arthroplasty were examined in a prospective controlled study to determine the efficacy and safety of a postoperative wound drainage autotransfusion system (Solcotrans, Smith & Nephew Richards, Memphis, TN)" 03/01/1977 - "This study shows that autotransfusion, when used with proper operating technique, is a most satisfactory technique for restoring blood volume in severe trauma cases and elective vascular operations" Get all the results and reference details, order at left...
3.	Colorectal Neoplasms (Colorectal Cancer) 05/13/1993 - "We carried out a randomized trial to investigate whether the prognosis in patients with colorectal cancer would be improved by a program of autologous blood transfusion as compared with the current practice of allogeneic transfusion" 01/01/1993 - "We carried out a randomized trial to investigate whether a predeposit autologous blood transfusion program improved prognosis in patients with colorectal cancer as compared to the current practice of allogeneic transfusion" 06/01/1993 - "Since all studies have been retrospective or uncontrolled, we performed a prospective controlled study in randomized groups of patients suffering from colorectal cancer and compared the effects of allogeneic and autologous blood transfusions" 01/01/2002 - "The Authors stress the basic importance of autotransfusions as well in patients surgically treated for colorectal cancer." 07/01/1995 - "We conclude that the use of a predeposit autologous blood transfusion programme does not improve the prognosis in colorectal cancer patients" Get all the results and reference details, order at left...
4.	Shock 08/01/1994 - "Mortality was not improved by intraoperative autotransfusion; however, the incidence of severe shock was 55.5% in those patients treated by autotransfusion, compared with 38.5% in the standard blood replacement group." 02/01/1993 - "The mortality rate was not clearly improved by autotransfusion, but among these 12 patients shock was present in 7 instances (58.3%), compared to 5 out of 14 subjects (35.7%) operated on before autotransfusion devices were available.(ABSTRACT TRUNCATED AT 250 WORDS)" 03/01/2005 - "CONCLUSION: Operative laparoscopy in patients with hopovolemic shock can be safely and effectively performed by experienced laparoscopists with the aid of optimal anesthesia, advanced cardiovascular monitoring, and autologous blood transfusion." 11/01/2002 - "CONCLUSIONS: Operative laparoscopy in patients with hypovolemic shock can be safely and effectively performed by experienced laparoscopists with the aid of optimal anesthesia, advanced cardiovascular monitoring and autologous blood transfusion." 04/01/1997 - "Autotransfusion was performed more frequently in the presence of hypovolaemic shock and more severe haemoperitoneum" Get all the results and reference details, order at left...
5.	Neoplasms (Cancer) 03/01/2002 - "OBJECTIVE: To study the effect of allogeneic, syngeneic, and autologous blood transfusion on the growth rate of the KHT tumor in a C3H murine model" 01/01/1996 - "Clinical studies fail to verify or to exclude the lethal risk of tumor spread after intraoperative autotransfusion in tumor surgery" 01/01/1994 - "The only realistic randomized study would compare different transfusion strategies (allogenic, leukocyte poor allogenic and autologous blood transfusion) to determine which is the best for cancer patients" 11/01/1986 - "The objective of this study was to examine the benefits and safety of autotransfusion in patients undergoing major surgery of genitourinary tumors" 12/01/2005 - "Cancer has remained an absolute contraindication to autotransfusion because of the unproven concern about reinfusion of malignant cells" Get all the results and reference details, order at left...
177 Diseases and 514 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Heparin (Liquaemin)
2.	Anti-Bacterial Agents (Antibiotics)
3.	Potassium
4.	Cytokines
5.	Aspirin (Acetylsalicylic Acid)
6.	MB Form Creatine Kinase
7.	Troponin T (T, Troponin)
8.	Lactic Acid
9.	Warfarin (Coumadin)
10.	Tranexamic Acid (AMCA)
74 Drugs and Important Bio-Agents and 79 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Blood Transfusion (Blood Transfusions)
2.	Hepatectomy
3.	Coronary Artery Bypass (Coronary Artery Bypass Surgery)
4.	Hemodilution
5.	Resuscitation
52 Therapies and Procedures and 123 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>